Use of Serotonergic Drugs in Canada for Gastrointestinal Motility Disorders: Results of a Retrospective Cohort Study

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left" rowspan="3">Inclusion criteria</td><td class="align_left">Age ≥ 18</td></tr><tr><td class="align_left">Diagnosis of GI motility disorder</td></tr><tr><td class="align_left">Referred for consideration of bowel resection </td></tr><tr><td class="align_center" colspan="2"><hr/></td></tr><tr><td class="align_left" rowspan="2">Exclusion criteria</td><td class="align_left">Inflammatory bowel disease</td></tr><tr><td class="align_left">Motility disorder secondary to spinal cord injury</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Scientifica

tab1

Table 1

Table 1: Use of Serotonergic Drugs in Canada for Gastrointestinal Motility Disorders: Results of a Retrospective Cohort Study 